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Abstract. Pathogenicity, virulence and resistance of infection-causing bacteria are 
noteworthy problems in clinical settings, even after disinfection practices and an-
tibiotic courses. Although it is common knowledge that these traits are associated 
to phenotypic and genetic variations, recent studies indicate that colony morphol-
ogy variations are a sign of increased bacterial resistance to antimicrobial agents 
(i.e. antibiotics and disinfectants) and altered virulence and persistence.  
The ability to search for and compare similar phenotypic appearances within 
and across species is believed to have vast potential in medical diagnose and clini-
cal decision making. Therefore, we are developing a novel phenotypic ontology, 
the Colony Morphology Ontology (CMO), to share knowledge on the colony 
morphology variations of infection-causing bacteria. A study on the morphologi-
cal variations of Pseudomonas aeruginosa and Staphylococcus aureus strains, two 
pathogenic bacteria associated with nosocomial infections, supported the devel-
opment of CMO. We are also developing a new Web-based framework for the 
modelling and analysis of biofilm phenotypic signatures, supported by the CMO. 
This framework, named MorphoCol, will enable data integration and interopera-
bility across research groups and other biological databases.  
Keywords: infection-causing bacteria, biofilms, colony morphology, phenotype 
ontology, microbial database. 
1   Introduction 
In the clinical context, bacteria can be isolated from various sources such as  
patients, indwelling medical devices (e.g. catheters, prostheses, pacemakers,  
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endotracheal tubes), biological fluids (e.g. blood, urine and sputum) and abiotic 
surfaces (e.g. clinical and medical equipment and air). In addition, bacteria are 
usually isolated from biofilms, i.e. organised microbial communities entrapped on 
protective polymeric matrices, which are formed in a variety of biotic [1] and 
abiotic surfaces [2].  
Bacterial persistence due to biofilm formation is a noteworthy downside in 
clinical settings, challenging disinfection and antibiotic procedures. Recent studies 
have pointed out colony morphology variations as a sign of increased resistance to 
antimicrobial agents (i.e. antibiotics and disinfectants) as well as of altered viru-
lence traits and persistence of infection-causing microorganisms. Small colony 
variants (SCV) [3-5] and mucoid variants [6, 7] are examples of this phenomenon 
– e.g. the reduced size and the mucoidity of colony variants appear to be linked to 
a higher resistance to some significant antibiotics of medical use, such as van-
comicin, kanamycin and ciprofloxacin.  
Colony observation has thus become a crucial asset to medical diagnose and 
clinical decision making. However, the characterization has to go well beyond the 
simple identification of the microorganisms involved and some qualitative or 
quantitative description of the altered colony morphology. Despite of the simplic-
ity of colony observation procedures, they often diverge on the experimental set-
tings (namely, the conditions of cultivation) and colony morphology is likely to be 
altered under different conditions [8, 9].  
The development of computational tools in assistance of phenotypic data depo-
sition and further comparison is the key to integrate phenotypic observations into 
clinical routines. The challenge lays on establishing standard laboratorial guide-
lines and consensual criteria to identify the morphological characteristics of the 
colonies and then, creating a suitable and unambiguous computational representa-
tion for both the experiment profile and microscopic observations.  
This work proposes the Colony Morphology Ontology (CMO), a novel ontol-
ogy in support of the comprehensive annotation of colony phenotypic studies.  
This ontology supports MorphoCol, a Web-based framework suitable for the 
modelling and analysis of biofilm phenotypic signatures. The framework is being 
submitted to in-house testing and will be soon made publicly available at 
http://stardust.deb.uminho.pt/morphocol/.  
2   The Colony Morphology Ontology 
One of the signs of bacterial adaptability to aggressive environments is the change 
between distinct phenotypes similar to a mechanism On/Off. This changeability is 
augmented when bacteria face antimicrobial pressures or switch their mode of 
growth to the biofilm state [10]. A rapid tool to notice this variability is the spread 
of bacterial cultures on solid media and the observation of the morphology of the 
colonies adopted by bacteria. But, in order to take full advantage of these outputs, 
researchers are in need of controlled vocabulary to annotate the experimental set-
tings and the parameters used to characterise the morphotypes unequivocally.  
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The rationale of the CMO is to unify the vocabulary commonly used to de-
scribe colony morphologies within and between research and clinician groups and 
therefore being able to perform large-scale study comparison. This ontology is a 
module of a more comprehensive ontology on biofilm studies that describes the 
overall concept of biofilm signature as being a set of information on the microor-
ganisms, the laboratory procedures, the antimicrobial susceptibility and virulence 
profiles (Fig. 1 – the top frame). 
The hierarchical structure of the ontology is represented by a directed acyclic 
graph and the terms hold relationships of the type “part_of” – which represent 
part-whole relationships - and the type “is_a” – defining subtypes. The “microor-
ganism” sub-tree (Fig. 1-a) embraces the identification of the infection-causing 
microorganism regarding the reference collection and the source from which it has 
been isolated (patient, indwelling devices, medical surfaces, etc.). Microbiologists 
need a bacteria identification to be able to compare studies and extrapolate the 
main phenotypic conclusions, i.e. it is not reasonable to consider the comparisons 
between different bacterial species.  
The “experimental procedure” sub-tree (Fig. 1-b) encompasses the subclasses 
“growth assay”, “plating assay” and “stress assay”, “molecular assay”, “omics as-
say” and “in vivo assay”. A growth assay characterises a set of parameters associ-
ated to bacterial growth, such as growth media, temperature, pH, time of growth, 
aeration, cell mode of growth, etc. Stress assays study the antimicrobial action 
(biocide, bacteriostatic and surfactant) of chemical and physical stressors on 
biofilms. Plating assay include the operational parameters associated to the spread 
of the bacterial cultures onto solid media and the development of the colonies. 
Molecular, ‘omics’ and in vivo assays address the use of high-throughput methods, 
such as polymerase chain reaction (PCR), expressing cloning, DNA arrays, 
MALDI-MS, gel electrophoresis, and in vivo techniques and conditions that may 
be used to confirm the preliminary identification and performs the comprehensive 
characterisation of the morphotypes. Again, results are comparable if and only if 
they were produced under the same culture and plating conditions. 
The CMO sub-tree contains one root term “colony morphology” with two di-
rect descendants: the terms “qualitative measure” and “quantitative measure” (Fig. 
1-c). Colony morphology is firstly analysed in terms of qualitative parameters 
such as form (circular, irregular, filamentous, etc.), margin (entire, undulated, 
curled, etc.), surface (homogeneous, heterogeneous), texture (smooth, rough), ele-
vation, size and colour. Then, it is quantified in terms of frequency, i.e. the num-
ber of colonies of a given morphotype variant per the total number of colonies in 
the plate. 
The “antimicrobial susceptibility” sub-tree reports the identification of the 
morphotype according its tolerance to a range (and concentrations) of antimicrobi-
als (antibiotics, disinfectants and biocides). The “virulence” sub-tree profiles the 
pathogenicity of colony variants in terms of virulence factors such as motility, en-
zymes production, tissue invasion ability and so on. 
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medical equipment (PAI), and S. aureus ATCC 25923. The aim of this study is to 
evaluate the impact of experimental settings (in particular the solid media growth 
and incubation time) and the susceptibility profile of the colonies.  
 
 
 
 
 
 
Fig. 2 The experimental scheme to obtain, identify and characterize colonies of unstressed 
and stressed cultures. Data obtained on virulence and antimicrobial resistance about each 
morphotype was attached to experiment signature. 
As illustrated in Fig. 2, bacteria are cultured on tryptic soy broth (TSB) and agar 
(TSA) media at 37 °C. During a period of 24 hours, bacteria are cultured in suspen-
sion (planktonic state) and in biofilm. Next, planktonic and biofilm cells are ex-
posed to different antimicrobial agents of clinical use, namely to peroxide hydrogen 
and benzalkonium chloride. Then, non-stressed and stressed planktonic and biofilm 
cells are spread onto different solid media to observe and characterise the colonies 
at different incubation times. The observation of colony morphology was supported 
by directly placing petri plates on magnifying glass and photographed. 
For our use case, it was possible to observe that the morphology of the colonies 
was strongly dependent of the experimental conditions. Data obtained revealed 
that the morphology of colonies was strongly dependent of the strain, cell mode of 
growth, type of solid media and incubation time. For only three bacterial strains it 
was observed more than one hundred distinct colonies. Also, the stressed cultures 
of all the strains have exhibited colony diversity. Fig. 3 presents some examples of 
the colonies observed. 
To include in CMO annotation: persistence of P. aeruginosa biofilms after hydro-
gen peroxide stress; colony diversity of S. aureus on different solid growth media; an-
tibiotic susceptibility of different types of SCV. 
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Strain: P. aeruginosa ATCC 
Diameter: 1,5 cm 
Colour: yellow 
Colony classification: LIRC 
(a) 
 
Strain: Isolated P. aeruginosa 
Diameter: 1,2 cm 
Colour: light brown 
Colony classification: LRSC 
(b) 
 
Strain: Isolated P. aeruginosa 
Diameter: 0,2 cm 
Colour: light brown 
Colony classification: RSCV 
(c) 
 
Strain: Isolated P. aeruginosa 
Diameter: 0,2 cm 
Colour: light brown 
Colony classification: RSCV 
(d) 
Strain: Isolated P. aeruginosa 
Diameter: 0,2 cm 
Colour: light brown 
Colony classification: SwSCV 
(e) 
 
Strain: S. aureus ATCC 
Diameter: 0,25 cm 
Colour: light brown 
Colony classification: SCV 
(f) 
Fig. 3 Examples of colony morphology diversity and the corresponding CMO annotations: 
(a) larger (more than 3 mm of diameter), irregular and rough colonies (LIRC) formed by P. 
aeruginosa ATCC; (b) larger, regular and smooth colonies (LRSC) with craters formed by 
the isolated P. aeruginosa; (c), (d) and (e) are SCV (less than 3 mm of diameter) formed by 
isolated P. aeruginosa under antimicrobial stress and (f) formed by S. aureus ATCC. The 
SCV exhibited distinct surfaces: (c) and (d) present a rough surface (RSCV), (e) has a 
smooth and wrinkled surface (SwSCV) and (f) has smooth surface (SSCV). The coloured 
bar indicates the scale of the image: black bars = 1 mm, white bars = 0,5 mm. 
These data provide novel insights into the proteomic alterations that occur dur-
ing the complex process of morphotype switching, and lend support to the idea 
that this is associated with a fitness advantage in vivo. 
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Table 1 The ciprofloxacin susceptibility profile of the SCV of P. aeruginosa ATCC and 
isolated P. aeruginosa. Analytical assessment: minimal inhibitory concentration (MIC) and 
minimal bactericidal concentration (MBC). 
Microorganism Morphotype 
Ciprofloxacin (mg/L)
MIC MBC 
P. aeruginosa ATCC
 LIRC 0,1563 0,625 
Isolated P. aeruginosa
 LISC 0,0391 0,625 
 SrSCV 0,0781 1,25 
 RSCV 0,0781 0,625 
 SwSCV 0,0781 1,25 
4   Conclusions and Future Work 
Rapid identification of pathogenic microorganisms is crucial in medical diagnosis 
and clinical decision-making. Specifically, the ability to search for and compare 
similar phenotypic appearances within and across species is believed to have vast 
clinical potential. In this work, we propose a novel ontology on colony morphol-
ogy – the CMO – as a step to the development of a fully integrated modelling and 
analysis framework for biofilm signatures. This approach has the potential to fa-
cilitate to efforts to link details on colony morphologies to specific environmental 
stressors and make our understanding of adaptive evolution more comprehensive. 
Further development and refinement of the CMO will occur continuously and 
in parallel with phenotype annotation; thus, the evolution of the ontology will re-
flect the complexity with which phenotypes are described in biofilm research. The 
creation of terms will be based on need, specifically by curation of primary litera-
ture, by annotation of in-house phenotypic studies and by expert input from mem-
bers of the biofilm research community.  
Based on CMO, a public platform – MorphoCol – is under construction for 
deposition, description and characterization of colony morphologies. Thus, Mor-
phoCol will help the consistent representation of colony morphology data. 
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